Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Skinvisible (SKVI) Short-Term Debt issuances (2016 - 2019)

Skinvisible's Short-Term Debt issuances history spans 5 years, with the latest figure at -$3395.0 for Q2 2019.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to -$3395.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $595.0, a 85.09% decrease, with the full-year FY2018 number at $3990.0, changed 0.0% from a year prior.
  • Short-Term Debt issuances hit -$3395.0 in Q2 2019 for Skinvisible, down from $3990.0 in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for SKVI hit a ceiling of $51485.0 in Q1 2015 and a floor of -$47495.0 in Q2 2015.
  • Historically, Short-Term Debt issuances has averaged $714.58 across 5 years, with a median of $2307.0 in 2016.
  • The widest YoY moves for Short-Term Debt issuances: up 90.82% in 2016, down 97.83% in 2016.
  • Tracing SKVI's Short-Term Debt issuances over 5 years: stood at -$31447.0 in 2015, then surged by 90.82% to -$2886.0 in 2016, then skyrocketed by 238.25% to $3990.0 in 2017, then changed by 0.0% to $3990.0 in 2018, then tumbled by 185.09% to -$3395.0 in 2019.
  • Business Quant data shows Short-Term Debt issuances for SKVI at -$3395.0 in Q2 2019, $3990.0 in Q1 2019, and $3990.0 in Q1 2018.